News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Yüksel Ürün: US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer
Mar 28, 2024, 03:11

Yüksel Ürün: US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer

Yüksel Ürün, Professor of Medical Oncology at Ankara University School of Medicine, shared a post on X:

“US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer!”

Yüksel Ürün: US FDA approves mirvetuximab soravtansine-gynx for FRα+ platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer

View additional information.

Source: Yüksel Ürün/X

Ankara University School of Medicine cancer fallopian tube cancer FDA approval Mirvetuximab Mirvetuximab Soravtansine OncoDaily Oncology Ovarian Cancer primary peritoneal cancer soravtansine-gynx US FDA Yüksel Ürün
Special Coverage
OncoDaily Pulse
Aug 21, 2025, 10:23
Archana Ajmera: Meet the Experts of VIRO 2025
OncoDaily Pulse
Aug 21, 2025, 10:08
Yüksel Ürün: Meet the Experts of VIRO 2025
Voices
Aug 21, 2025, 09:46
Pratiti Bandopadhayay: Urgent Need to Sustain Funding for Pediatric Brain Tumor Trials
Voices
Aug 21, 2025, 09:30
Jana Ellegast: Inflammatory Signaling in the Pathogenesis of AML
Insight
Aug 21, 2025, 09:02
Humaid Al-Shamsi: Outcomes of HSCT from Matched Related Donors in Pediatric Patients
Celebrities
Aug 21, 2025, 08:40
World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer
Insight
Aug 21, 2025, 08:17
Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark
Science
Aug 21, 2025, 06:29
Moazzam Shahzad: The Impact of MRD Status after Matched Donor alloHCT in AML
Insight
Aug 21, 2025, 00:36
Tom Powles: IMVIGOR011 Trial Brings ctDNA-Guided Adjuvant Immunotherapy to Bladder Cancer
Voices
Aug 21, 2025, 00:00
Kristina Lindemann: Advancing Gynecological Cancer Trials with ENGOT in Norway
Voices
Aug 20, 2025, 23:11
Anne Susanty: Sharing the Stage with Guillermo Chantada at SIOP 2024
Career Updates
Aug 20, 2025, 22:08
Devon J Shedlock Named Vice President and Head of Oncology Cell Therapy Technology at Genentech